Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2011

Stratify or adjust? Dealing with multiple populations when
evaluating rare variants
Robert C. Culverhouse
Washington University School of Medicine in St. Louis

Anthony L. Hinrichs
Washington University School of Medicine in St. Louis

Brian K. Suarez
Washington University School of Medicine in St. Louis

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs
Part of the Medicine and Health Sciences Commons

Recommended Citation
Culverhouse, Robert C.; Hinrichs, Anthony L.; and Suarez, Brian K., ,"Stratify or adjust? Dealing with
multiple populations when evaluating rare variants." BMC Proceedings. 5,Suppl 9. S101. (2011).
https://digitalcommons.wustl.edu/open_access_pubs/523

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Culverhouse et al. BMC Proceedings 2011, 5(Suppl 9):S101
http://www.biomedcentral.com/1753-6561/5/S9/S101

PROCEEDINGS

Open Access

Stratify or adjust? Dealing with multiple
populations when evaluating rare variants
Robert C Culverhouse1,2*, Anthony L Hinrichs3, Brian K Suarez3,4
From Genetic Analysis Workshop 17
Boston, MA, USA. 13-16 October 2010

Abstract
The unrelated individuals sample from Genetic Analysis Workshop 17 consists of a small number of subjects from
eight population samples and genetic data composed mostly of rare variants. We compare two simple approaches
to collapsing rare variants within genes for their utility in identifying genes that affect phenotype. We also compare
results from stratified analyses to those from a pooled analysis that uses ethnicity as a covariate. We found that the
two collapsing approaches were similarly effective in identifying genes that contain causative variants in these
data. However, including population as a covariate was not an effective substitute for analyzing the subpopulations
separately when only one subpopulation contained a rare variant linked to the phenotype.
Background
The Genetic Analysis Workshop 17 (GAW17) unrelated
individuals sample is derived from the pilot3 study of
the 1000 Genomes Project (http://www.1000genomes.
org) and consists of genotypes of 697 subjects drawn
from 8 populations. Of the 24,487 exomic single-nucleotide polymorphisms (SNPs) in the data, 9,433 (38.5%)
occur only once in a single individual and 18,131
(74.0%) occur with less than 1% minor allele frequency
(MAF). Phenotypes provided include sex, age, smoking
(yes/no), ethnic population, three quantitative traits (Q1,
Q2, and Q4), and the dichotomous trait Affected. A single genetic model based on additive genetic effects was
used for all subjects. For a full description of the data
simulation, see Almasy et al. [1]. As a result of these
conditions, we took a gene-centric approach to our analysis. We had two goals: (1) to determine whether any
genes that contribute to the generating model could be
detected using only rare variants in these extremely
sparse data and (2) to determine whether population
stratification would be better dealt with using stratified
analyses or simply including population as a covariate.
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We were blind to the generating model before the
GAW17 meeting so that our analyses would not be
biased by knowledge of the true model. The blind was
broken at the GAW17 meeting, and our knowledge of
the generating model was used for the evaluation of
methods discussed in this paper.

Methods
Our analyses were based on 2,448 genes, each having at
least 1 rare SNP (minor allele frequency [MAF] < 0.01)
from the total 3,205 genes included in the data. This
arbitrary threshold was chosen as a compromise
between what is typically considered common (MAF ≥
0.05) and the fact that the sample size in the provided
data was modest. After inspecting the generating model,
we discovered that 5 out of 39 causative variants for Q1
fell between these two thresholds, as did 2 of the 51 variants for affection status. We used a regression framework to examine the quantitative trait Q1 and the
dichotomous trait Affected.
Collapsing rare variants

We generated two genetic variables based on related collapsing approaches. The first variable was simply a count
of how many rare alleles an individual carried for a particular gene. The second variable was dichotomous, indicating whether or not an individual carried at least one
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rare allele in a particular gene. Both of these collapsing
approaches were previously discussed by Li and Leal [2]
as part of a more sophisticated analytic approach that
incorporates both rare and common variants.
Using multiple data replicates

Because of the sparseness of the information in the unrelated individuals sample, we believed that a single data
replicate would likely be underpowered for this analysis.
Each replicate contains exactly the same genotypes, making most approaches to combining information from
multiple replicates prone to spurious associations. The
focus on rare variants in this analysis exacerbates this
problem. We chose to perform a meta-analysis of the
multiple replicates. For these particular data, this
approach provides a scalability feature that allows easy
comparisons of differing sample sizes. For the full data,
we examined single replicates, and meta-analyzed sequential groups of 10 replicates each (e.g., replicates 1–10, 11–
20, etc.) and the first 50 replicates. For the much smaller
subpopulation samples, we meta-analyzed sequential
groups of 10 replicates each and the first 50 replicates.
An initial examination of the quantitative traits indicated
that Q4 was largely determined by the covariates Sex, Age,
and Smoking. This made Q4 a good candidate to use to
evaluate the extent to which combining multiple replicates
would lead to entirely extraneous false positives. We therefore performed the same regression analyses and metaanalyses on Q4 as we did for Q1. The use of Q4 as a negative control for false positives allowed us to evaluate the
chances of the single set of genotypes giving rise to
entirely spurious signals. We note that the use of a negative control lets us evaluate only the extent to which
entirely spurious signals might arise from the use of multiple copies of the same genotypes. However, this approach
cannot provide an estimate of the extent to which small
spurious signals, resulting from such things as rare variants in individuals with extreme phenotypes or modest
correlations between a causative gene and a null gene,
might be amplified when using multiple replicates.
Population stratification

We evaluated two methods for dealing with population
stratification: (1) analyzing the strata in separate analyses
and (2) pooling data from all strata, using population as
a covariate. Through the use of meta-analyses of varying
numbers of data replicates, we could also compare
results from similarly sized single-population analyses
and pan-population analyses.
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dichotomous indicator) as the predictor of interest. We
noted that the dichotomous Affected phenotype was
highly correlated with the quantitative traits. As a result,
we believed that our top signals from a straightforward
analysis of this trait might reveal only genes associated
with Q1 or Q2. Therefore, to detect genes associated
directly with the Affected phenotype, in our logistic
regression analyses of affection status we included Q1, Q2,
and Q4 as well as Sex, Age, Population, and Smoking as
covariates.
We considered the possibility that if a causative variant were found in only one subpopulation, it might be
advantageous to analyze that subpopulation separately.
To evaluate this possibility, we conducted a second set
of analyses, performed separately on each genetically
distinct subpopulation. To determine whether any of the
samples could be pooled, we first performed an EIGENSTRAT analysis [3]. The results suggested that the
Asian samples (Han Chinese, Denver Chinese, and Japanese) could be pooled, as could the European samples
(European-descended Utah population [CEPH] and Tuscans). The differences between the two African populations were greater than any of the other groups but
were still modest. As a consequence, we decided to
separate them. A detailed plot of the two African populations can be found in Hinrichs et al. [4].
Finally, we note that one of the CEPH subjects
(NA7347) was an extreme outlier for Q1 across most of
the data replicates. This subject was excluded from our
analyses.
Our multireplicate analysis plan proceeded as follows:
First, we analyzed k individual data replicates and
retained the p-values. Then we performed meta-analyses
using Fisher’s statistic,
k

∑ ln(p),

F = −2

(1)

1

which under the null hypothesis would be expected to
have a chi-square distribution with 2k degrees of freedom (df). The nonindependence of the genotypes
between the data replicates violates the distributional
assumptions. However, our chief goal was to determine
whether any of the true signals would stand out from
the bulk of the noise in this sparse data.
Because of the large number of tests performed, we
used 10−6 as our threshold for statistical significance. All
statistical analyses were performed in SAS [5].

Results
Analyses

Q1 results

Our analyses for Q1 were based on linear regression using
Sex, Age, Smoking, and Population as covariates and one
of our two ways of coding the genes (quantitative count or

Table 1 provides a summary of the results of the analyses of Q1 using single data replicates, using Population
as a covariate and both collapsing variables. We note
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Table 1 Q1 single replicate results for combined populations (200 replicates, N = 697 each)
Count (quantitative)

Indicator (dichotomous)

Gene

Chromosome

Median (p)

Min, max

Median (p)

Min, max

FLT1

13

3.1 × 10−19

1.1 × 10−29, 5.0 × 10−10

9.7 × 10−19

9.2 × 10−30, 1.2 × 10−10

ZNF605

12

7.2 × 10−10

5.0 × 10−19, 1.8 × 10−4

7.2 × 10−10

5.0 × 10−19, 1.8 × 10−4

TAS2R48

12

8.1 × 10−9

9.4 × 10−16, 2.0 × 10−2

3.0 × 10−8

4.8 × 10−15, 2.3 × 10−2

ZNF84

12

1.4 × 10−8

8.5 × 10−18, 1.7 × 10−3

1.4 × 10−9

8.5 × 10−18, 1.7 × 10−3

Linear regression results from using two collapsing approaches for rare variants in a gene. Analyses used population as a covariate. The median, minimum (min),
and maximum (max) p-value for each gene that passed our threshold of 10−6 for at least 50% of the replicates are listed.

that the same four genes passed our significance threshold for both of the collapsing variables (Count and Indicator) and had similar p-values. The high degree of
similarity between the two collapsing approaches held
true throughout our analyses. As an example, Figure 1
illustrates the relationship between the −log(p) values
for the genes in a meta-analysis of Q1 using the first
50 replicates. Each point represents the results of metaanalysis of a single gene. The horizontal position is −log
(p) from the analysis based on the Indicator variable; the
vertical position is −log(p) from the Count variable. The
correlation between the values from the two collapsing
methods is 0.92. If we eliminate the top four outlying
values, the remaining values still have a correlation of
0.85. For this reason, we report only the results from
the Count variable in the remainder of this paper.
A stratified analysis of the individual populations did
not have any results that passed our significance threshold. However, the European sample (CEPH and Tuscan
sample combined) had FLT1 as its top result, with p <
10−5. The inability of any of these samples to pass the
significance threshold was expected because of the small
sample size. Results from meta-analyses of 10 replicates
at a time are found in Table 2. In each case the top signal passing the significance threshold is a gene modeled
as contributing to the phenotype. In addition, although
the top signal from the Luhya sample, VEGFA, did not
quite pass the significance threshold (N = 1,080), it was
a true positive, and the next ranked gene was three
orders of magnitude less significant. This signal was
consistent throughout the replicates and would become
significant when more replicates were added to the
meta-analysis. In contrast, we note that VEGFA was
ranked 406th in the meta-analysis results for the combined population sample (N = 6,970) with median p =
4.6 × 10−4.
Q4 results

In contrast, our analysis of the negative control phenotype (Q4) resulted in no gene with a median p < 0.05 in
the combined population sample or any of the subpopulations. Furthermore, in none of our meta-analyses, even

including all 200 data replicates, did we achieve a p-value
that passed our significance threshold (10−6) either in the
combined data or in any subpopulation.
Affected phenotype results

For the combined population data no gene was significant in the individual data replicates. Only one gene,
PRKCA on chromosome 17, was significant in metaanalyses of 10 replicates (N = 6,970, median p = 2.1 ×
10−9; range of p, 9.0 × 10−13 to 3.4 × 10−6). PRKCA was
a causative gene in the model. Another causative gene,
PIK3C2B, was ranked 5 out of 2,448 in the meta-analyses of 10 replicates. However, it would not reach significance unless all 200 replicates were meta-analyzed.
In the stratified analyses none of the subpopulation
samples passed the significance threshold, in single
replicate analyses or in a meta-analysis of 10 replicates.
However, if 50 replicates were meta-analyzed, PRKCA
became significant in the Asian sample (N = 16,050, p =
3.4 × 10−11) and in the Yoruba sample (N = 5,600, p =
5.6 × 10−9) and was trending toward significance in the
Luhya sample (N = 5,400, p = 4.3 × 10−5). This signal
was not seen in the combined European sample (N =
7,500, p = 0.35).

Discussion
Clearly, some contributing genes (FLT1, VEGFA,
PRKCA) could be detected by an examination of rare
variants in the unrelated subjects. However, it turned
out that our second goal (determining whether stratified
analyses or a population covariate would be more effective in dealing with population stratification in these
data) gave rise to the most interesting results.
FLT1 contained multiple rare variants with large effect
on Q1. The signals from this gene were strong in the
European and Yoruba populations and present in the
Asian populations. (The rare variants in FLT1 were not
significant in the Luhya sample, even if 200 replicates
were meta-analyzed.) Because the signal was present in
subsamples representing more than 84% of the data,
pooling the data and using population as a covariate
maximized power.
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Figure 1 Comparison of Q1 results from two gene-wise collapsing methods for rare variants. Each data point represents the results of
meta-analysis of a single gene using the first 50 data replicates. The horizontal position is −log(p) from the analysis based on the Indicator
variable; the vertical position is based on the Count variable. The correlation between the two values is 0.92. If we eliminate the top four values,
the correlation is still 0.86.

In contrast, VEGFA, found in an analysis of the Luhya
sample, was not near the top of the list in the combined
analysis. It was not until we meta-analyzed 50 replicates
of the full data (total N = 34,850) that this gene surpassed the 10−6 significance threshold (p = 1.4 × 10−14).
In contrast, meta-analysis of the first 50 replicates of the
Luhya subjects alone (total N = 5,400) resulted in an
extremely low p-value (p = 2.1 × 10−94). This is because
the rare variant for VEGFA is private to the Luhya
population. As a result, including samples from other
populations merely introduces noise into the signal. It is
interesting to note that VEGFA corresponds to the highest linkage signal found in a linkage analysis of the
family data [4].
We note that the phenotypes were modeled identically
for the different populations. As a consequence, one
might have believed a priori that a combined analysis
(perhaps not even using population as a covariate)

might be the most powerful approach. However, as illustrated by the results for VEGFA, this need not be the
case. This suggests that it might be worthwhile to analyze multipopulation data both ways (stratified and
adjusted), despite the multiple testing penalty.
In these data we also found that the two tested
approaches to collapsing performed similarly, particularly for the top signals. This simply suggests that in
these data the outliers in phenotype were not also outliers in terms of the count variable for any genes.
Clearly, this cannot be generalized to other genetic
models.
Finally, although our top signal in each analysis result
was a true signal, there were many more highly significant false positives than we would have expected. We
learned from the analysis of Q4 that it is unlikely that
these spurious results were a completely random effect
of using multiple replicates of the same genotypes. Two
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Table 2 Q1 subpopulation results (20 meta-analyses, 10 replicates each)
Subpopulation
Europea
b

Asia

N

Gene

Chromosome

Median (p)

Min, max

1,560

FLT1

13

1.0 × 10−45

1.1 × 10−52, 4.6 × 10−37

KDR

4

1.9 × 10−41

8.7 × 10−58, 1.0 × 10−32

FLT1

13

9.5 × 10−17

9.3 × 10−25, 4.6 × 10−13

−6

1.7 × 10−14, 1.7 × 10−2

3,210

Yorubac
d

Luhya

1,120
1,080

VEGFA

6

4.2 × 10

Linear regression results using the Count coding for rare variants in a gene. The median, minimum (min), and maximum (max) p-value for the top causative
genes that passed our threshold of 10−6 for at least 50% of the replicates are listed, plus the top result from the Luhya sample, which does not quite meet the
threshold.
a
There were 78 lower ranked false positives (p < 10−6). The highest ranked false positive had p < 10−40.
b
There were no genes that passed the significance threshold of 10−6. Top gene had median p = 0.13.
c
There were 23 lower ranked false positives (i.e., p < 10−6). The highest ranked had p > 10−14.
d
No genes passed the significance threshold of 10−6 in at least 50% of the replicates. The second ranked gene had p > 10−3.

other possible causes come to mind. First, rare variants
carried by individuals with extreme phenotypes could
give rise to such results. We tested this idea by performing some analyses that included the individual from the
CEPH sample (NA7347) who had an extreme Q1 value
(>5 standard deviations above the mean) in nearly every
replicate. We found that multiple genes that were not
included in the model but for which this individual was
the only carrier of rare variants became significant. Second, the signals could actually be in the data, although
they were not included in the generating model. We
note that many false positives in these data have been
reported as consistently arising under a variety of analysis methods. For a detailed discussion of this aspect of
the data, see Luedtke et al. [6].

Conclusions
In our analyses we found that in the GAW17 data, the
two collapsing methods produced similar results. More
important, these analyses showed that even with the
identical genetic model applied to multiple subpopulations, sample size is not the only factor that determines
power. If rare causative variants are private to a subpopulation, stratified analysis might be more powerful than
a combined analysis, despite a considerable decrease in
sample size.
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